Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer.

Br J Cancer · 2012 · PMC3261677 · PMID 22215062

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

showed a trendP =0.05actually significant

There was no difference between the age groups in this aspect ( P =0.34, χ 2 -test), however, the pts >65 years showed a trend towards higher grades of toxicity ( P =0.05, χ 2 -test).

also in 35,913 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.